Ranked #1
Myeloma Crowd Radio: Dr. Robert Kyle, MD, Mayo Clinic
Myeloma Crowd Radio: Dr. Robert Kyle, MD, Mayo Clinic
For over sixty years Dr. Robert Kyle, MD of the Mayo Clinic led the way in myeloma research and was the pioneer that def... Read more
16 Sep 2016
•
1hr 20mins
Ranked #2
mPatient Myeloma Radio: Dr. Eric Bartee, MD, PhD, MUSC
mPatient Myeloma Radio: Dr. Eric Bartee, MD, PhD, MUSC
When patients harvest stem cells in preparation for autologous transplant, can they be "cleaned up" or can all residual ... Read more
14 Nov 2014
•
1hr 3mins
Ranked #3
Myeloma Crowd Radio: Robert Orlowski, MD, PhD, MD Anderson Cancer Center
Myeloma Crowd Radio: Robert Orlowski, MD, PhD, MD Anderson Cancer Center
The year 2018 promises to be an exciting one in multiple myeloma research. Learn what about key findings from the recent... Read more
5 Jan 2018
•
1hr 4mins
Ranked #4
mPatient Myeloma Radio: Dr. Vincent Rajkumar, MD, Mayo Clinic
mPatient Myeloma Radio: Dr. Vincent Rajkumar, MD, Mayo Clinic
The guidelines for myeloma treatment are changing to allow earlier treatment, even without some of the typical symptoms ... Read more
20 Nov 2014
•
1hr 6mins
Ranked #5
Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD Anderson Cancer Center 2019
Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD Anderson Cancer Center 2019
Major progress is being made in the field of multiple myeloma including a vast array of immunotherapy options. Learn abo... Read more
8 Jan 2019
•
1hr 3mins
Ranked #6
Myeloma Crowd Radio: Luciano Costa, MD, PhD, University of Alabama
Myeloma Crowd Radio: Luciano Costa, MD, PhD, University of Alabama
Adequate treatment of multiple myeloma at diagnosis is a key issue for patients because their first remission is typical... Read more
16 Apr 2018
•
1hr
Ranked #7
Myeloma Crowd Radio: Ravi Vij, MD, Washington University
Myeloma Crowd Radio: Ravi Vij, MD, Washington University
A new monoclonal antibody called Isatuximab is advancing through clinical trials and is getting closer to FDA approval. ... Read more
6 Feb 2019
•
1hr 1min
Ranked #8
Myeloma Crowd Radio/MCRI: Dr. Frits van Rhee, UAMS and Dr. Stephen Russell, Mayo
Myeloma Crowd Radio/MCRI: Dr. Frits van Rhee, UAMS and Dr. Stephen Russell, Mayo
The measles virus used successfully for a patient with relapsed myeloma is now a well known and exciting story shared on... Read more
29 May 2015
•
1hr 19mins
Ranked #9
Myeloma Crowd: Paul Richardson, MD, Dana Farber Cancer Institute
Myeloma Crowd: Paul Richardson, MD, Dana Farber Cancer Institute
The myeloma landscape is rapidly changing with many new advancements. Paul Richardson, MD of the Dana Farber Cancer Inst... Read more
3 Aug 2018
•
1hr 28mins
Ranked #10
Myeloma Crowd Radio/MCRI: Drs. Gareth Morgan, Niels Weinhold and Christoph Heuck
Myeloma Crowd Radio/MCRI: Drs. Gareth Morgan, Niels Weinhold and Christoph Heuck
UAMS has led the way in studying the biology of myeloma cells to find new therapies. We now know that multiple myeloma p... Read more
18 May 2015
•
1hr 22mins
Ranked #11
Myeloma Crowd Radio: Paul Richardson, MD, Dana Farber Cancer Institute
Myeloma Crowd Radio: Paul Richardson, MD, Dana Farber Cancer Institute
A new treatment called Selinexor was recently approved for highly relapsed multiple myeloma patients. Learn how experts ... Read more
31 Jul 2019
•
1hr 1min
Ranked #12
mPatient Radio: Dr. Jens Lohr, Dana Farber Cancer Institute and BROAD Institute
mPatient Radio: Dr. Jens Lohr, Dana Farber Cancer Institute and BROAD Institute
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. ... Read more
28 Feb 2014
•
1hr 4mins
Ranked #13
Myeloma Crowd Radio: Clifford Reid, PhD, Travera
Myeloma Crowd Radio: Clifford Reid, PhD, Travera
How much does a cancer cell weigh? And why does it matter? As cancer cells die, they change their weight in a matter of ... Read more
23 Oct 2019
•
1hr 1min
Ranked #14
mPatient Radio: Dr. Leif Bergsagel, MD, Mayo Clinic Scottsdale
mPatient Radio: Dr. Leif Bergsagel, MD, Mayo Clinic Scottsdale
Join us as we talk with Dr. Leif Bergsagel about his research to subdivide myeloma by genetic type and apply different t... Read more
7 Mar 2014
•
1hr 10mins